Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

NCT01124734

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

NCT01666353

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

NCT01118832

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Johns Hopkins Medicine Baltimore, Maryland, United States

View Trial Details

Completed

PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

NCT02492815

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Boston, Massachusetts, United States

Outcome Sciences Inc Dba Outcome Boston, Massachusetts, United States

Local Institution Linz, Austria

Local Institution Brussels, Belgium

View all 17 locations

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center Rockledge, Pennsylvania, United States

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Melanoma Image Analysis Algorithm (MIAA) Validation Study

NCT02612168

Conditions: Disease, Malignant Melanoma, Melanoma, +13 more
Locations: Royal Devon and Exeter Exeter, Devon, United Kingdom

Whipps Corss Hospital Leytonstone, London, United Kingdom

Royal Stoke University Hospital Stoke, Staffordshire, United Kingdom

Russells Hall Hospital Dudley, West Midlands, United Kingdom

View Trial Details

Completed

A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases

NCT02941744

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: UZ Brussel Jette, Brabant, Belgium

View Trial Details

Completed

Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients

NCT02296996

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: UZ Brussel Brussels, Belgium

View Trial Details

Completed

A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])

NCT03139513

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Centre Hospitalier d'Albi Albi, France

Hopital Prive D Antony; Dermatologie Antony, France

Chic Cote Basque Bayonne; Medecine II Bayonne, France

CHU Besançon - Hôpital Jean Minjoz Besançon, France

View all 33 locations

View Trial Details

Completed

SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma

NCT02986867

Conditions: Carcinoma, Carcinoma, Transitional Cell, Cervical Carcinoma in Situ, +23 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Melanoma

Melanoma trial results

Related conditions